Your browser doesn't support javascript.
loading
Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.
Arroyo, M G; Couëtil, L L; Nogradi, N; Kamarudin, M M; Ivester, K M.
Afiliación
  • Arroyo MG; Veterinary Clinical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, IN.
  • Couëtil LL; Veterinary Clinical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, IN.
  • Nogradi N; Veterinary Clinical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, IN.
  • Kamarudin MM; Veterinary Clinical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, IN.
  • Ivester KM; Veterinary Clinical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, IN.
J Vet Intern Med ; 30(4): 1333-7, 2016 Jul.
Article en En | MEDLINE | ID: mdl-27282625
BACKGROUND: The (R)-enantiomer of racemic albuterol (levalbuterol) has bronchodilatory properties whereas the (S)-enantiomer causes adverse effects in human airways, animal models, and isolated equine bronchi. Levalbuterol is commercially available and improves pulmonary function of asthmatic patients with a longer duration of effect than albuterol. OBJECTIVE: To determine the dose at which inhaled levalbuterol produces maximal bronchodilatory effect (EDmax) and determine its duration of action in recurrent airway obstruction (RAO)-affected horses in comparison to racemic albuterol. ANIMALS: Nine horses with inducible and reversible RAO. METHODS: Randomized, crossover trial. Horses were challenged with moldy hay to induce airway obstruction. Horses were treated with nebulized albuterol or levalbuterol chosen randomly. Pulmonary function testing (PFT) was measured before and for up to 3 hours after bronchodilatation challenge. Maximum change in transpulmonary pressure (DPmax ) was measured to assess the dose effect and duration of action of each drug. After a 24 hours washout period, the bronchodilatation challenge was repeated with the second bronchodilator. RESULTS: The duration of effect was 60 minutes for albuterol and 120 minutes for levalbuterol. The dose of bronchodilator EDmax was not significantly different between albuterol and levalbuterol (EDmax = 125.0 [125-125 µg] and EDmax = 188 [125-188 µg] respectively; P = .068). The magnitude of bronchodilatation was not significantly different between the 2 treatments (61.1 and 59.9% decrease in DPmax for albuterol and levalbuterol respectively; P = .86). CONCLUSIONS AND CLINICAL IMPORTANCE: Levalbuterol is as effective a bronchodilator as albuterol; although levalbuterol lasts twice as long as albuterol, its duration of action is still too short to make it practical for RAO treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Albuterol / Levalbuterol / Enfermedades de los Caballos / Enfermedades Pulmonares Obstructivas Límite: Animals Idioma: En Revista: J Vet Intern Med Asunto de la revista: MEDICINA INTERNA / MEDICINA VETERINARIA Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Albuterol / Levalbuterol / Enfermedades de los Caballos / Enfermedades Pulmonares Obstructivas Límite: Animals Idioma: En Revista: J Vet Intern Med Asunto de la revista: MEDICINA INTERNA / MEDICINA VETERINARIA Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos